Log In
Print this Print this

arbekacin (ME1100)

  Manage Alerts
Collapse Summary General Information
Company Meiji Seika Pharma Co. Ltd.
DescriptionAminoglycoside antibiotic
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationPneumonia
Indication DetailsTreat hospital-acquired bacterial pneuomonia (HABP) and ventilator-associated bacterial pneumonia (VABP)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today